264. Debates on Tropical Vaccines: Malaria and Dengue
Saturday, October 10, 2015: 2:00 PM-3:30 PM
Room: 6--CF
Co-organized with the American Society of Tropical Medicine and Hygiene (ASTMH)

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • summarize the current challenges in malaria and dengue vaccine development, deployment, and registration
  • describe the challenges in taking a vaccine from the laboratory to the field

Target Audience: Vaccinologists, Scientists, Researchers, Public health practitioners, Pharmacists, Nurses, Microbiologists, Members-in-training, Lab personnel, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Pediatric ID, Investigative ID, Global ID, Adult ID

Panelists:  Stephen Hoffman, MD, FIDSA, Sanaria , W. Ripley Ballou, MD, GSK Vaccines , Duane Gubler, DSc, FIDSA, Duke-NUS Graduate Medical School and Anna Durbin, MD, Johns Hopkins Bloomberg School of Public Health

Moderators:  David Kaslow, MD, PATH and Edward T. Ryan, MD, DTMH, FIDSA, Division of Infectious Diseases, Massachusetts General Hospital

CME Credits: No CME is offered for this session

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-200-L01-P


D. Kaslow, None

E. T. Ryan, None

S. Hoffman, Sanaria Inc: Board Member and Employee , Salary

W. R. Ballou, GSK: Employee and Shareholder , Salary

D. Gubler, Takeda: Scientific Advisor and Shareholder , Consulting fee
Sanofi Oasteur: Scientific Advisor , Consulting fee
Novartis Unst of Tropical Dis: Scientific Advisor , Consulting fee
Jannsen: Scientific Advisor , Consulting fee
Merck: Scientific Advisor , nothing
Hawaii Biotech: Scientific Advisor , nothing

A. Durbin, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.